Telmisartan NDC 59746-440

NDC codes

FDA NDC Directory

Product NDC (as listed)59746-440Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59746-0440Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
59746-440-32	59746044032	3 BLISTER PACK in 1 CARTON (59746-440-32) / 10 TABLET in 1 BLISTER PACK (59746-440-12)Marketed from Aug 22, 2016

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Telmisartan
Generic name (nonproprietary): telmisartan
Active ingredients: Telmisartan — 40 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Jubilant Cadista Pharmacuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 204164
Marketing start: Aug 22, 2016
Listing expires: Dec 31, 2026
Other FDA classes: Angiotensin 2 Receptor Antagonists (Mechanism)
Identifiers: Product ID 59746-440_482ba8bc-d601-48d8-9d50-8fa4d2c255feSPL ID 482ba8bc-d601-48d8-9d50-8fa4d2c255feSPL set ID e1a907a7-fad9-a860-8639-4c6136c85734RxCUI 205304, 205305, 282755UNII U5SYW473RQUPC 0359746440121
Pharmacologic class: Angiotensin 2 Receptor Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459746044032 followed by a unit qualifier and the quantity

Package 59746-0440-32. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 15, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Telmisartan tablets, USP are angiotensin II receptor blocker (ARB) indicated for: Treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. (1.1) 1.1 Hypertension Telmisartan tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. Con…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 204164

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 204164
Product	Strength	Form · route	Labeler	Product NDC
Telmisartan	Telmisartan 20 mg/1	TabletOral	Jubilant Cadista Pharmacuticals Inc.	59746-439
Telmisartan	Telmisartan 80 mg/1	TabletOral	Jubilant Cadista Pharmacuticals Inc.	59746-441